Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The long-term natural history of chronic obstructive pulmonary disease (COPD) in terms of successive severe exacerbations and mortality is unknown. METHODS: The authors formed an inception cohort of patients from their first ever hospitalisation for COPD during 1990-2005, using the healthcare databases from the province of Quebec, Canada. Patients were followed until death or 31 March 2007, and all COPD hospitalisations occurring during follow-up were identified. The hazard functions of successive hospitalised COPD exacerbations and all-cause mortality over time were estimated, and HRs adjusted for age, sex, calendar time and comorbidity. RESULTS: The cohort included 73 106 patients hospitalised for the first time for COPD, of whom 50 580 died during the 17-year follow-up, with 50% and 75% mortality at 3.6 and 7.7 years respectively. The median time from the first to the second hospitalised exacerbation was around 5 years and decreased to <4 months from the 9th to the 10th. The risk of the subsequent severe exacerbation was increased threefold after the second severe exacerbation and 24-fold after the 10th, relative to the first. Mortality after a severe exacerbation peaked to 40 deaths per 10 000 per day in the first week after admission, dropping gradually to 5 after 3 months. CONCLUSIONS: The course of COPD involves a rapid decline in health status after the second severe exacerbation and high mortality in the weeks following every severe exacerbation. Two strategic targets for COPD management should include delaying the second severe exacerbation and improving treatment of severe exacerbations to reduce their excessive early mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
The natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
The Statistical Analysis of Failure Time Data
Young, W. R. (1981) · Journal of Quality Technology · doi:10.1080/00224065.1981.11978770 · Cited by 1,666
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Rodríguez, R. (2007) · Cited by 1,391
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Chronic obstructive pulmonary disease: current burden and future projections
Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., Schmid, V., & Buist, S. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00025805 · Cited by 1,335
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Deaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Evidence for Improving Palliative Care at the End of Life: A Systematic Review
Lorenz, K. A., Lynn, J., Dy, S. M., Shugarman, L. R., Wilkinson, A., Mularski, R. A., Morton, S. C., Hughes, R. G., Hilton, L. K., Maglione, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00010 · Cited by 591
A Chronic Disease Score with Empirically Derived Weights
Clark, D. O., Korff, M. V., Saunders, K., Balugh, W. M., & Simon, G. E. (1995) · Medical Care · doi:10.1097/00005650-199508000-00004 · Cited by 551
Self-management education for patients with chronic obstructive pulmonary disease
Effing, T., Monninkhof, E. E., van der Valk, P. P. D. L. P. M., Zielhuis, G. G., Walters, E. H., van der Palen, J. J., & Zwerink, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002990.pub2 · Cited by 536 · cited 1×
“This has been achieved with structured self-management plans.(36) Finally, our results suggest that patients in whom severe exacerbations occur frequently and cluster together may be at a stage in their disease where end-oflife care may need to be envisaged.”
ResultValidation of diagnostic codes within medical services claims
Wilchesky, M., Tamblyn, R. M., & Huang, A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00246-4 · Cited by 439
Ernst, P., Gonzalez, A. V., Brassard, P., & Suissa, S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200611-1630oc · Cited by 389
Self-citationInhaled and Nasal Glucocorticoids and the Risks of Ocular Hypertension or Open-angle Glaucoma
Garbe, E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540330044033 · Cited by 350
Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
Aaron, S. D., Vandemheen, K. L., Hebert, P., Dales, R., Stiell, I. G., Ahuja, J., Dickinson, G., Brison, R., Rowe, B. H., Dreyer, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023161 · Cited by 350
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Suissa, S., Kezouh, A., & Ernst, P. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.06.019 · Cited by 317
Self-citationSevere exacerbations and BODE index: Two independent risk factors for death in male COPD patients
Soler-Cataluña, J. J., Martínez-García, M. Á., Sánchez, L. S., Tordera, M. P., & Sánchez, P. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.12.005 · Cited by 309
Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD
Miravitlles, M., Murio, C., Guerrero, T., & Gisbert, R. (2002) · Chest · doi:10.1378/chest.121.5.1449 · Cited by 283
Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD
McGhan, R., Radcliff, T., Fish, R., Sutherland, E. R., Welsh, C., & Make, B. (2007) · Chest · doi:10.1378/chest.06-3018 · Cited by 282
Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Quint, J. K., Goldring, J. J. P., Baghai-Ravary, R., & Wedzicha, J. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1067oc · Cited by 276
Roberts, C. M. (2002) · Thorax · doi:10.1136/thorax.57.2.137 · Cited by 252
Contemporary Management of Acute Exacerbations of COPD
Quon, B. S., Gan, W. Q., & Sin, D. D. (2008) · Chest · doi:10.1378/chest.07-1207 · Cited by 247
Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations
Roberts, C. M., Stone, R. A., Buckingham, R. J., Pursey, N. A., Lowe, D., & On behalf of the National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project (NCROP) implementation group (2011) · Thorax · doi:10.1136/thx.2010.153114 · Cited by 233
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
Hoogendoorn, M., Hoogenveen, R. T., Rutten-van Mölken, M. P., Vestbo, J., & Feenstra, T. L. (2011) · European Respiratory Journal · doi:10.1183/09031936.00043710 · Cited by 228
Association of Inhaled Corticosteroid Use With Cataract Extraction in Elderly Patients
Garbe, E. (1998) · JAMA · doi:10.1001/jama.280.6.539 · Cited by 201
Deaths: preliminary data for 2008.
Miniño, A., Xu, J., & Kochanek, K. D. (2010) · PubMed · Cited by 181
Inhaled and Nasal Corticosteroid Use and the Risk of Fracture
Suissa, S., Baltzan, M., Kremer, R., & Ernst, P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-640oc · Cited by 153
Self-citationNew drugs for exacerbations of chronic obstructive pulmonary disease
Hansel, T. T., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61342-8 · Cited by 117
Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Ernst, P., Baltzan, M., Deschênes, J., & Suissa, S. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00043005 · Cited by 115
Self-citationTransitional Care: A Critical Dimension of the Home Healthcare Quality Agenda
Naylor, M. D. (2006) · Journal for Healthcare Quality · doi:10.1111/j.1945-1474.2006.tb00594.x · Cited by 89
Calverley, P. M. A., Anderson, J., Celli, B. R., Ferguson, G., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · Research Explorer (The University of Manchester) · Cited by 74
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma
Garbe, E. (1997) · JAMA · doi:10.1001/jama.277.9.722 · Cited by 70
Gender differences in survival following hospitalisation for COPD
Gonzalez, A. V., Suissa, S., & Ernst, P. (2010) · Thorax · doi:10.1136/thx.2010.141978 · Cited by 54
Self-citationTemporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., & Wedzicha, J. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.182.7.985 · Cited by 48
FitzGerald, J. M. (2011) · Thorax · doi:10.1136/thx.2010.156760 · Cited by 46
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.
Garbe, E., LeLorier, J., Boivin, J.-F., & Suissa, S. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71674-5 · Cited by 6
Self-citation
Cited by
Chronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219
Chronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
Self management for patients with chronic obstructive pulmonary disease
Zwerink, M., Brusse-Keizer, M., van der Valk, P. D., Zielhuis, G. A., Monninkhof, E. M., van der Palen, J., Frith, P. A., & Effing, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002990.pub3 · Cited by 572
Wedzicha, J. A., Decramer, M., Ficker, J. H., Niewoehner, D. E., Sandström, T., Taylor, A. F., D'Andrea, P., Arrasate, C., Chen, H., & Banerji, D. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70052-3 · Cited by 535
BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults
Davidson, A. C., Banham, S., Elliott, M., Kennedy, D., Gelder, C., Glossop, A., Church, A. C., Creagh-Brown, B., Dodd, J. W., Felton, T., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-208209 · Cited by 426
Metadata
- Authors
- Suissa, S., Dell'Aniello, S., & Ernst, P.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2012-06-08
- Volume
- 67
- Issue
- 11
- Pages
- 957-963
- ISSN
- 0040-6376 (ISSN-L)
- 1468-3296
- OpenAlex
- W2131237771
- Cited by
- 779
- References
- 46
- FWCI
- 35.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.